MAPT and Alzheimer disease: In summary, the present study highlights that knock-in expression of a mutated tau protein favors the development of glucose metabolism impairments and pancreatic β-cell dysfunction upon metabolic stress, supporting not only a role of tau pathology in the development of metabolic disturbances in AD and FTLD patients but providing new insights on the physiological role of tau in the control of peripheral metabolism.